The deal will give Advanz an increased presence in the treatment of rare diseases
from PharmaTimes: News RSS https://ift.tt/1X0Nelj
Post Top Ad
Monday, 4 July 2022
Advanz finalises acquisition of Intercept operations across Europe and Canada
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment